abrdn Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-9,105
| Closed | -$720K | – | 194 |
|
2016
Q3 | $720K | Sell |
9,105
-1,341,078
| -99% | -$106M | ﹤0.01% | 177 |
|
2016
Q2 | $113M | Sell |
1,350,183
-907,106
| -40% | -$75.7M | 0.51% | 66 |
|
2016
Q1 | $207M | Buy |
2,257,289
+41,510
| +2% | +$3.81M | 0.95% | 44 |
|
2015
Q4 | $224M | Sell |
2,215,779
-168,193
| -7% | -$17M | 0.95% | 42 |
|
2015
Q3 | $234M | Sell |
2,383,972
-45,834
| -2% | -$4.5M | 1% | 37 |
|
2015
Q2 | $285M | Sell |
2,429,806
-647,211
| -21% | -$75.8M | 1.2% | 34 |
|
2015
Q1 | $302M | Sell |
3,077,017
-442,100
| -13% | -$43.4M | 1.23% | 33 |
|
2014
Q4 | $332M | Sell |
3,519,117
-35,382
| -1% | -$3.34M | 1.31% | 33 |
|
2014
Q3 | $378M | Buy |
3,554,499
+467,736
| +15% | +$49.8M | 1.44% | 25 |
|
2014
Q2 | $256M | Buy |
3,086,763
+11,383
| +0.4% | +$944K | 1.14% | 31 |
|
2014
Q1 | $218M | Buy |
3,075,380
+56,841
| +2% | +$4.03M | 1.04% | 40 |
|
2013
Q4 | $227M | Buy |
3,018,539
+181,688
| +6% | +$13.7M | 1.2% | 26 |
|
2013
Q3 | $178M | Sell |
2,836,851
-14,027
| -0.5% | -$882K | 1.03% | 38 |
|
2013
Q2 | $146M | Buy |
+2,850,878
| New | +$146M | 0.93% | 42 |
|